Vanda Pharmaceuticals Inc.

Connor, Clark & Lunn Investment Management Ltd. VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

743,546

Value ($000)

6,558

Weight

0.0%

2014 Q1 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	6,558	0.0%	743,546	12/31/2025
2025 Q3	11/13/2025	4,514	0.0%	904,544	9/30/2025
2025 Q2	8/7/2025	4,099	0.0%	868,419	6/30/2025
2025 Q1	5/12/2025	4,267	0.0%	929,644	3/31/2025
2024 Q4	2/10/2025	3,925	0.0%	819,382	12/31/2024
2024 Q3	11/8/2024	3,663	0.0%	780,933	9/30/2024
2024 Q2	8/9/2024	4,098	0.0%	725,366	6/30/2024
2024 Q1	5/9/2024	2,848	0.0%	692,878	3/31/2024
2023 Q4	2/9/2024	1,120	0.0%	265,449	12/31/2023
2023 Q3	11/13/2023	1,147	0.0%	265,449	9/30/2023
2023 Q2	8/10/2023	1,749	0.0%	265,449	6/30/2023
2023 Q1	5/10/2023	1,522	0.0%	224,150	3/31/2023
2022 Q4	2/10/2023	1,617	0.0%	218,808	12/31/2022
2022 Q3	11/10/2022	1,175	0.0%	118,930	9/30/2022
2022 Q2	8/5/2022	758	0.0%	69,548	6/30/2022
2020 Q2	8/13/2020	484	0.0%	42,341	6/30/2020
2014 Q1	5/14/2014	2,595	0.0%	144,707	3/31/2014